SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Bogdan Michael) "

Sökning: WFRF:(Bogdan Michael)

  • Resultat 281-290 av 293
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
281.
  •  
282.
  •  
283.
  • Sønderby, Ida E., et al. (författare)
  • 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans
  • 2021
  • Ingår i: Translational Psychiatry. - : Nature Publishing Group. - 2158-3188. ; 11:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.
  •  
284.
  • Thomas, Liza, et al. (författare)
  • Evaluation of Left Atrial Size and Function : Relevance for Clinical Practice
  • 2020
  • Ingår i: Journal of the American Society of Echocardiography. - : Elsevier. - 0894-7317 .- 1097-6795. ; 33:8, s. 934-952
  • Forskningsöversikt (refereegranskat)abstract
    • Left atrial (LA) structural and functional evaluation have recently emerged as powerful biomarkers for adverse events in a variety of cardiovascular conditions. Moreover, noninvasive evaluation of LA pressure has gained importance in the characterization of the hemodynamic profile of patients. This review de-scribes the methodology, benefits and pitfalls of measuring LA size and function by echocardiography and provides a brief overview of the prognostic utility of newer echocardiographic metrics of LA geometry and function (i.e., three-dimensional volumes, longitudinal strain, and phasic function parameters).
  •  
285.
  •  
286.
  • Wenander, Henrik, et al. (författare)
  • Administrative Law
  • 2022. - 2
  • Ingår i: Swedish Legal System. - 9789139021629 ; CXCVII, s. 62-84
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)abstract
    • Administrative law in the Swedish understanding forms the field of law regulating the activities of public authorities and others carrying out activities within the public sector. As in other Nordic and continental legal systems, the field is commonly divided into two parts. General administrative law (allmän förvaltningsrätt) covers the common principles and legal provisions applicable as default rules. Also administrative court procedure has traditionally been treated as a part of general administrative law. Special administrative law (speciell förvaltningsrätt) provides rules applicable in special fields. The latter includes e.g. public order and safety law, environmental law, migration law, social welfare law and education law. The chapter describes the Swedish general administrative law, including administrative court procedure law, whereas some of the special administrative fields are treated in other chapters of this book.
  •  
287.
  •  
288.
  • Witjes, J. Alfred, et al. (författare)
  • EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer – An International Collaborative Multistakeholder Effort : Under the Auspices of the EAU-ESMO Guidelines Committees
  • 2020
  • Ingår i: European Urology. - : Elsevier. - 0302-2838 .- 1873-7560. ; 77:2, s. 223-250
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial.OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management.DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts prior to voting during a consensus conference.SETTING: Online Delphi survey and consensus conference.PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management.OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), and 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus).RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these statements, 33 (28%) achieved level 1 consensus and 49 (42%) achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease, and the evolving role of checkpoint inhibitor therapy in metastatic disease.CONCLUSIONS: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time when further evidence is available to guide our approach.PATIENT SUMMARY: This report summarises findings from an international, multistakeholder project organised by the EAU and ESMO. In this project, a steering committee identified areas of bladder cancer management where there is currently no good-quality evidence to guide treatment decisions. From this, they developed a series of proposed statements, 71 of which achieved consensus by a large group of experts in the field of bladder cancer. It is anticipated that these statements will provide further guidance to health care professionals and could help improve patient outcomes until a time when good-quality evidence is available.
  •  
289.
  • Zaitlen, Noah, et al. (författare)
  • Informed Conditioning on Clinical Covariates Increases Power in Case-Control Association Studies
  • 2012
  • Ingår i: PLoS Genetics. - : Public Library of Science (PLoS). - 1553-7404. ; 8:11
  • Tidskriftsartikel (refereegranskat)abstract
    • Genetic case-control association studies often include data on clinical covariates, such as body mass index (BMI), smoking status, or age, that may modify the underlying genetic risk of case or control samples. For example, in type 2 diabetes, odds ratios for established variants estimated from low-BMI cases are larger than those estimated from high-BMI cases. An unanswered question is how to use this information to maximize statistical power in case-control studies that ascertain individuals on the basis of phenotype (case-control ascertainment) or phenotype and clinical covariates (case-controlcovariate ascertainment). While current approaches improve power in studies with random ascertainment, they often lose power under case-control ascertainment and fail to capture available power increases under case-control-covariate ascertainment. We show that an informed conditioning approach, based on the liability threshold model with parameters informed by external epidemiological information, fully accounts for disease prevalence and non-random ascertainment of phenotype as well as covariates and provides a substantial increase in power while maintaining a properly controlled falsepositive rate. Our method outperforms standard case-control association tests with or without covariates, tests of gene x covariate interaction, and previously proposed tests for dealing with covariates in ascertained data, with especially large improvements in the case of case-control-covariate ascertainment. We investigate empirical case-control studies of type 2 diabetes, prostate cancer, lung cancer, breast cancer, rheumatoid arthritis, age-related macular degeneration, and end-stage kidney disease over a total of 89,726 samples. In these datasets, informed conditioning outperforms logistic regression for 115 of the 157 known associated variants investigated (P-value = 1x10(-9)). The improvement varied across diseases with a 16% median increase in chi(2) test statistics and a commensurate increase in power. This suggests that applying our method to existing and future association studies of these diseases may identify novel disease loci.
  •  
290.
  • Zhou, Bin, et al. (författare)
  • Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants
  • 2016
  • Ingår i: The Lancet. - : Elsevier B.V.. - 0140-6736 .- 1474-547X. ; 387:10027, s. 1513-1530
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: One of the global targets for non-communicable diseases is to halt, by 2025, the rise in the age standardised adult prevalence of diabetes at its 2010 levels. We aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the global target, and how changes in prevalence, together with population growth and ageing, are aff ecting the number of adults with diabetes.Methods: We pooled data from population-based studies that had collected data on diabetes through measurement of its biomarkers. We used a Bayesian hierarchical model to estimate trends in diabetes prevalence-defined as fasting plasma glucose of 7.0 mmol/L or higher, or history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs-in 200 countries and territories in 21 regions, by sex and from 1980 to 2014. We also calculated the posterior probability of meeting the global diabetes target if post-2000 trends continue.Findings: We used data from 751 studies including 4372000 adults from 146 of the 200 countries we make estimates for. Global age-standardised diabetes prevalence increased from 4.3% (95% credible interval 2.4-17.0) in 1980 to 9.0% (7.2-11.1) in 2014 in men, and from 5.0% (2.9-7.9) to 7.9% (6.4-9.7) in women. The number of adults with diabetes in the world increased from 108 million in 1980 to 422 million in 2014 (28.5% due to the rise in prevalence, 39.7% due to population growth and ageing, and 31.8% due to interaction of these two factors). Age-standardised adult diabetes prevalence in 2014 was lowest in northwestern Europe, and highest in Polynesia and Micronesia, at nearly 25%, followed by Melanesia and the Middle East and north Africa. Between 1980 and 2014 there was little change in age-standardised diabetes prevalence in adult women in continental western Europe, although crude prevalence rose because of ageing of the population. By contrast, age-standardised adult prevalence rose by 15 percentage points in men and women in Polynesia and Micronesia. In 2014, American Samoa had the highest national prevalence of diabetes (>30% in both sexes), with age-standardised adult prevalence also higher than 25% in some other islands in Polynesia and Micronesia. If post-2000 trends continue, the probability of meeting the global target of halting the rise in the prevalence of diabetes by 2025 at the 2010 level worldwide is lower than 1% for men and is 1% for women. Only nine countries for men and 29 countries for women, mostly in western Europe, have a 50% or higher probability of meeting the global target.Interpretation: Since 1980, age-standardised diabetes prevalence in adults has increased, or at best remained unchanged, in every country. Together with population growth and ageing, this rise has led to a near quadrupling of the number of adults with diabetes worldwide. The burden of diabetes, both in terms of prevalence and number of adults aff ected, has increased faster in low-income and middle-income countries than in high-income countries.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 281-290 av 293
Typ av publikation
tidskriftsartikel (109)
bokkapitel (75)
recension (34)
annan publikation (23)
bok (18)
konferensbidrag (15)
visa fler...
samlingsverk (redaktörskap) (12)
forskningsöversikt (5)
doktorsavhandling (1)
visa färre...
Typ av innehåll
övrigt vetenskapligt/konstnärligt (183)
refereegranskat (108)
populärvet., debatt m.m. (1)
Författare/redaktör
Farzadfar, Farshad (11)
Jonas, Jost B. (11)
Brenner, Hermann (9)
Khader, Yousef Saleh (9)
Sepanlou, Sadaf G. (9)
Shiri, Rahman (9)
visa fler...
Kasaeian, Amir (8)
Khang, Young-Ho (8)
Malekzadeh, Reza (8)
Nagel, Gabriele (8)
Qorbani, Mostafa (8)
McKee, Martin (7)
Lindskoug, Patrik (7)
Geleijnse, Johanna M ... (7)
Alkerwi, Ala'a (7)
Topor-Madry, Roman (7)
Hay, Simon I. (6)
Bensenor, Isabela M. (6)
Lotufo, Paulo A. (6)
Rivera, Juan A. (6)
Yonemoto, Naohiro (6)
Murray, Christopher ... (6)
Khubchandani, Jagdis ... (6)
Majeed, Azeem (6)
Lundqvist, Annamari (5)
Koyanagi, Ai (5)
Giwercman, Aleksande ... (5)
Tendera, Michal (5)
Kolh, Philippe (5)
Dean, Veronica (5)
Wade, Alisha N. (5)
Smith, N. (5)
Vlahos, L. (5)
Cooper, Cyrus (5)
Hardy, Rebecca (5)
Claessens, Frank (5)
Sjostrom, Michael (5)
Thijs, Lutgarde (5)
Staessen, Jan A (5)
Abbafati, Cristiana (5)
Guessous, Idris (5)
Kumar, G. Anil (5)
Mohan, Viswanathan (5)
Mokdad, Ali H. (5)
Tran, Bach Xuan (5)
Werdecker, Andrea (5)
Kengne, Andre P. (5)
Kosen, Soewarta (5)
McGarvey, Stephen T. (5)
Mirrakhimov, Erkin M ... (5)
visa färre...
Lärosäte
Lunds universitet (237)
Uppsala universitet (37)
Karolinska Institutet (14)
Göteborgs universitet (9)
Umeå universitet (9)
Stockholms universitet (8)
visa fler...
Kungliga Tekniska Högskolan (7)
Chalmers tekniska högskola (6)
Linköpings universitet (5)
Högskolan Dalarna (5)
Sveriges Lantbruksuniversitet (5)
Luleå tekniska universitet (4)
Södertörns högskola (4)
Linnéuniversitetet (3)
Mittuniversitetet (2)
Naturhistoriska riksmuseet (1)
Blekinge Tekniska Högskola (1)
visa färre...
Språk
Engelska (162)
Svenska (118)
Tyska (4)
Tjeckiska (3)
Franska (2)
Slovakiska (2)
visa fler...
Finska (1)
Lettiska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Samhällsvetenskap (229)
Naturvetenskap (26)
Medicin och hälsovetenskap (22)
Lantbruksvetenskap (4)
Teknik (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy